284 related articles for article (PubMed ID: 19459987)
41. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
[TBL] [Abstract][Full Text] [Related]
42. Comparison of genotypes of Streptococcus pneumoniae serotypes 6A and 6B before and after the introduction of PCV7 vaccination in Korea.
Baek JY; Ko KS; Kim SH; Kang CI; Chung DR; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2011 Apr; 69(4):370-5. PubMed ID: 21396531
[TBL] [Abstract][Full Text] [Related]
43. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine.
Calbo E; Díaz A; Cañadell E; Fábrega J; Uriz S; Xercavins M; Morera MA; Cuchi E; Rodríguez-Carballeira M; Garau J;
Clin Microbiol Infect; 2006 Sep; 12(9):867-72. PubMed ID: 16882291
[TBL] [Abstract][Full Text] [Related]
44. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use.
Pilishvili T; Zell ER; Farley MM; Schaffner W; Lynfield R; Nyquist AC; Vazquez M; Bennett NM; Reingold A; Thomas A; Jackson D; Schuchat A; Whitney CG
Pediatrics; 2010 Jul; 126(1):e9-17. PubMed ID: 20547641
[TBL] [Abstract][Full Text] [Related]
45. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
Fry AM; Facklam RR; Whitney CG; Plikaytis BD; Schuchat A
J Infect Dis; 2003 Sep; 188(5):643-52. PubMed ID: 12934179
[TBL] [Abstract][Full Text] [Related]
46. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
47. National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
Hsieh YC; Lin PY; Chiu CH; Huang YC; Chang KY; Liao CH; Chiu NC; Chuang YC; Chen PY; Chang SC; Liu JW; Yen MY; Wang JH; Liu CY; Lin TY
Vaccine; 2009 Sep; 27(40):5513-8. PubMed ID: 19615960
[TBL] [Abstract][Full Text] [Related]
48. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
Talbot TR; Poehling KA; Hartert TV; Arbogast PG; Halasa NB; Mitchel E; Schaffner W; Craig AS; Edwards KM; Griffin MR
Clin Infect Dis; 2004 Sep; 39(5):641-8. PubMed ID: 15356776
[TBL] [Abstract][Full Text] [Related]
49. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.
Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B
J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539
[TBL] [Abstract][Full Text] [Related]
50. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.
Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH
Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859
[TBL] [Abstract][Full Text] [Related]
51. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Andersen PH; Howitz M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2010 Mar; 28(14):2642-7. PubMed ID: 20096392
[TBL] [Abstract][Full Text] [Related]
52. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
[TBL] [Abstract][Full Text] [Related]
53. Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan.
Chiba N; Morozumi M; Sunaoshi K; Takahashi S; Takano M; Komori T; Sunakawa K; Ubukata K;
Epidemiol Infect; 2010 Jan; 138(1):61-8. PubMed ID: 19538821
[TBL] [Abstract][Full Text] [Related]
54. Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.
Shibl A; Memish Z; Pelton S
Int J Antimicrob Agents; 2009 May; 33(5):410.e1-9. PubMed ID: 18976887
[TBL] [Abstract][Full Text] [Related]
55. New insights on pneumococcal disease: what we have learned over the past decade.
Dagan R
Vaccine; 2009 Aug; 27 Suppl 3():C3-5. PubMed ID: 19552985
[TBL] [Abstract][Full Text] [Related]
56. Incidence of invasive pneumococcal disease among elderly people in Southern Catalonia, Spain, 2002-2009: an increase in serotypes not contained in the heptavalent conjugate vaccine.
Ochoa-Gondar O; Vila-Corcoles A
J Infect; 2011 Dec; 63(6):434-40. PubMed ID: 21875616
[TBL] [Abstract][Full Text] [Related]
57. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
[TBL] [Abstract][Full Text] [Related]
58. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Pelton SI; Song LY; Fenton T; Levin MJ; Nachman SA; Borkowsky W; Rosenblatt HM; Marcinak JF; Dieudonne A; Abrams EJ; Pathak I;
Pediatr Infect Dis J; 2006 Oct; 25(10):920-9. PubMed ID: 17006288
[TBL] [Abstract][Full Text] [Related]
59. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
[TBL] [Abstract][Full Text] [Related]
60. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period.
Liñares J; Ardanuy C; Pallares R; Fenoll A
Clin Microbiol Infect; 2010 May; 16(5):402-10. PubMed ID: 20132251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
